Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytesDiana M Feidt, Kathrin Klein, Ute Hofmann, et al.
Clinical Pharmacology and Therapeutics|March 9, 2007
Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizoleT Saussele, O Burk, J K Blievernicht, et al.
The Journal of Biological Chemistry|August 28, 2002
A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporterChristoph Michalski, Yunhai Cui, Anne T Nies, et al.
Pharmacogenetics and Genomics|December 14, 2005
Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populationsMarkus Schirmer, Mohammad R Toliat, Michael Haberl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2018
Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture LysatesFrederik Weiß, Helen S Hammer, Kathrin Klein, et al.
BMC Systems Biology|May 10, 2011
A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytesJoachim Bucher, Stephan Riedmaier, Anke Schnabel, et al.
Plos Computational Biology|January 5, 2016
Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic ModelingRoland Keller, Marcus Klein, Maria Thomas, et al.
Archives of Toxicology|September 4, 2014
Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanismsAndreas Bitter, Petra Rümmele, Kathrin Klein, et al.
Genome Medicine|December 27, 2011
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinomaElke Schaeffeler, Claus Hellerbrand, Anne T Nies, et al.
Clinical Pharmacology and Therapeutics|July 4, 2006
Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicityKatarzyna K Loboz, Annette S Gross, Kenneth M Williams, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytesDiana M Feidt, Kathrin Klein, Ute Hofmann, et al.
Clinical Pharmacology and Therapeutics|March 9, 2007
Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizoleT Saussele, O Burk, J K Blievernicht, et al.
The Journal of Biological Chemistry|August 28, 2002
A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporterChristoph Michalski, Yunhai Cui, Anne T Nies, et al.
Pharmacogenetics and Genomics|December 14, 2005
Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populationsMarkus Schirmer, Mohammad R Toliat, Michael Haberl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2018
Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture LysatesFrederik Weiß, Helen S Hammer, Kathrin Klein, et al.
BMC Systems Biology|May 10, 2011
A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytesJoachim Bucher, Stephan Riedmaier, Anke Schnabel, et al.
Plos Computational Biology|January 5, 2016
Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic ModelingRoland Keller, Marcus Klein, Maria Thomas, et al.
Archives of Toxicology|September 4, 2014
Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanismsAndreas Bitter, Petra Rümmele, Kathrin Klein, et al.
Genome Medicine|December 27, 2011
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinomaElke Schaeffeler, Claus Hellerbrand, Anne T Nies, et al.
Clinical Pharmacology and Therapeutics|July 4, 2006
Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicityKatarzyna K Loboz, Annette S Gross, Kenneth M Williams, et al.
Pageof 21